These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 26602825)
1. Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss. Saad S; Dharmapatni AASSK; Crotti TN; Cantley MD; Algate K; Findlay DM; Atkins GJ; Haynes DR Acta Biomater; 2016 Jan; 30():311-318. PubMed ID: 26602825 [TBL] [Abstract][Full Text] [Related]
2. Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation. Gomez C; Burt-Pichat B; Mallein-Gerin F; Merle B; Delmas PD; Skerry TM; Vico L; Malaval L; Chenu C Dev Dyn; 2005 Oct; 234(2):393-403. PubMed ID: 16145665 [TBL] [Abstract][Full Text] [Related]
3. Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles. Tian Y; Terkawi MA; Onodera T; Alhasan H; Matsumae G; Takahashi D; Hamasaki M; Ebata T; Aly MK; Kida H; Shimizu T; Uetsuki K; Kadoya K; Iwasaki N Front Immunol; 2020; 11():1720. PubMed ID: 32849609 [TBL] [Abstract][Full Text] [Related]
5. Wear and osteolysis in total joint replacements. Kadoya Y; Kobayashi A; Ohashi H Acta Orthop Scand Suppl; 1998 Feb; 278():1-16. PubMed ID: 9524528 [TBL] [Abstract][Full Text] [Related]
6. Semaphorin 3A gets involved in the establishment of mouse tooth eruptive pathway. Yu X; Zheng F; Du Y; Tang K; Wang W; Zhang S J Mol Histol; 2019 Oct; 50(5):427-434. PubMed ID: 31270650 [TBL] [Abstract][Full Text] [Related]
7. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465 [TBL] [Abstract][Full Text] [Related]
8. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Crotti TN; Smith MD; Findlay DM; Zreiqat H; Ahern MJ; Weedon H; Hatzinikolous G; Capone M; Holding C; Haynes DR Biomaterials; 2004 Feb; 25(4):565-73. PubMed ID: 14607494 [TBL] [Abstract][Full Text] [Related]
9. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Shen Z; Crotti TN; McHugh KP; Matsuzaki K; Gravallese EM; Bierbaum BE; Goldring SR Arthritis Res Ther; 2006; 8(3):R70. PubMed ID: 16613614 [TBL] [Abstract][Full Text] [Related]
10. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas. Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912 [TBL] [Abstract][Full Text] [Related]
12. Luteolin Stimulates Proliferation and Inhibits Late Differentiation of Primary Rat Calvarial Osteoblast Induced by High-dose Dexamethasone via Sema3A /NRP1/Pleixin A1. Zheng L Curr Pharm Biotechnol; 2021; 22(11):1538-1545. PubMed ID: 33327910 [TBL] [Abstract][Full Text] [Related]
13. The role of osteoblasts in peri-prosthetic osteolysis. O'Neill SC; Queally JM; Devitt BM; Doran PP; O'Byrne JM Bone Joint J; 2013 Aug; 95-B(8):1022-6. PubMed ID: 23908414 [TBL] [Abstract][Full Text] [Related]
14. The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. Holding CA; Findlay DM; Stamenkov R; Neale SD; Lucas H; Dharmapatni AS; Callary SA; Shrestha KR; Atkins GJ; Howie DW; Haynes DR Biomaterials; 2006 Oct; 27(30):5212-9. PubMed ID: 16806459 [TBL] [Abstract][Full Text] [Related]
15. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway. Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis. Yin Z; Gong G; Liu X; Yin J Front Immunol; 2023; 14():1274679. PubMed ID: 37860014 [TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142 [TBL] [Abstract][Full Text] [Related]
18. Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways. Ormsby RT; Solomon LB; Yang D; Crotti TN; Haynes DR; Findlay DM; Atkins GJ Acta Biomater; 2019 Mar; 87():296-306. PubMed ID: 30690207 [TBL] [Abstract][Full Text] [Related]
19. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway. Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671 [TBL] [Abstract][Full Text] [Related]
20. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption. Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]